title: Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Ueda
authors.forename: Yuki
authors.initials: Y
authors.lastname: Matsumura
authors.forename: Tomomi
authors.initials: T
authors.lastname: Egawa-Takata
authors.forename: Takahito
authors.initials: T
authors.lastname: Miyake
authors.forename: Takashi
authors.initials: T
authors.lastname: Miyatake
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Yoshino
authors.forename: Masami
authors.initials: M
authors.lastname: Fujita
authors.forename: Shinya
authors.initials: S
authors.lastname: Matsuzaki
authors.forename: Takuhei
authors.initials: T
authors.lastname: Yokoyama
authors.forename: Yukari
authors.initials: Y
authors.lastname: Miyoshi
authors.forename: Masato
authors.initials: M
authors.lastname: Yamasaki
authors.forename: Takayuki
authors.initials: T
authors.lastname: Enomoto
authors.forename: Tadashi
authors.initials: T
authors.lastname: Kimura
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D016016:Proportional Hazards Models; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D015996:Survival Rate